One confirmed target of mivaRNA is the protein Ly6K (lymphocyte antigen 6 complex, Locus K) (Bellutti et al., 2015), a protein associated with cell growth and implicated in several cancers such as lung, breast or head and neck (Vachon and Conn, 2015). The gene discussed is LY6K; the disease is cancer.